Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN

Plan to resume MAGNITUDE-2 patient enrollment and dosing FDA engagement ongoing regarding clinical hold on MAGNITUDE Phase 3 ...

IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY

Strategic Restructuring Eliminates Expenses Not Essential to the Phase 3 Study Khursheed Anwer, Ph.D., Executive Vice President and Chief Scientific Officer, will retire after nearly 12 years at the ...

Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)

Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 ...

Intellia Therapeutics Climbs After FDA Lifts Hold on Phase 3 Trial

The company said Tuesday that the FDA lifted the hold on an Investigational New Drug Application for a phase 3 clinical trial of nexiguran ziclumeran, or nex-z, for patients with a genetic disease ...

Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025

Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 ...
Investing.com Australia

Imunon stock rises following strategic restructuring to focus on Phase 3 trial

Imunon Inc (NASDAQ:IMNN) stock rose 2.9% in premarket trading Thursday after the clinical-stage company announced a strategic restructuring to reduce operating ex ...

Arsenal 3-2 Kairat Almaty: Kai Havertz and Viktor Gyokeres both score as Gunners complete perfect Champions League league phase campaign

Report as Arsenal completed a 100 per cent Champions League league phase by beating Kairat Almaty; Viktor Gyokeres put ...
TMCnet

Sagimet Announces Positive 52-Week Data from License Partner Ascletis' Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in ...

“The topline results from Ascletis’ Phase 3 open-label acne trial in China build additional confidence in the clinical potential of FASN inhibition in acne,” said David Happel, Chief Executive Officer ...
Pharmabiz

Immunic presents additional phase 2 CALLIPER trial data for vidofludimus calcium in patients with progressive MS at the ACTRIMS Forum 2026

Immunic presents additional phase 2 CALLIPER trial data for vidofludimus calcium in patients with progressive MS at the ACTRIMS Forum 2026: New York Friday, February 6, 2026, 16:0 ...

Surgery for quantum bits: Bit-flip errors corrected during superconducting qubit operations

Quantum computers hold great promise for exciting applications in the future, but for now they keep presenting physicists and ...
Monthly Prescribing Reference

Phase 3 Trials Support Amlitelimab for Moderate to Severe Atopic Dermatitis

Both dosage regimens of amlitelimab were associated with statistically significant improvements in skin clearance and disease severity vs placebo in the US estimand. Topline data were announced from ...
Nasdaq

Crinetics Doses First Patient In Phase 2/3 BALANCE-CAH Trial Of Atumelnant

(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) has dosed the first patient in its Phase 2/3 trial of investigational drug Atumelnant for the treatment of classic congenital adrenal hyperplasia in ...